Background. Elderly patients with advanced chronic kidney disease require accurate outcome descriptions to make treatment decisions. Methods. The PSPA [Parcours de soins des personnes âgées (Treatment pathways for elderly patients)] prospective multicentre cohort study included 573 such patients with a median age of 82 [interquartile range (IQR) 79-86] years and a median estimated glomerular filtration rate of 14 (IQR 11-17) mL/min/ 1.73 m 2 and studied their 5-year outcomes according to the dialysis component of their treatment plans. Results. Mean follow-up for the overall cohort was 34.5 6 21 months and the 5-year survival rate was 27%. During follow-up, 288 (50%) patients started dialysis and 237 (42%) died before dialysis. At baseline, the four possible dialysis plans were dialysis when needed (38%), stable without mention of a dialysis plan (40%) and dialysis specifically excluded by the patient's (9%) or nephrologist's decision (12%). These baseline plans were associated with death and dialysis start. Follow-up plans were those decided during the study period: dialysis when needed for 47%, stable without mention of a dialysis plan for 20% and dialysis excluded at any time for 32%. For the subgroup of patients who started dialysis, those whose follow-up plan was dialysis started under better conditions than those who had stable or no dialysis follow-up plans before starting. However, survival afterwards did not differ significantly. Conclusions. These findings indicate that nephrology care should accommodate changes over time in older patients'
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An author video to accompany this article is available at: https://academic.oup.com/ndt/pages/author_videos.
I N T R O D U C T I O N
Individuals >75 years of age are a growing population in highincome countries and account for $40% of incident dialysis patients in the French national end-stage renal disease (ESRD) registry (REIN) [1] . Compared with younger patients, elderly people with chronic kidney disease (CKD) have a higher risk of dying than of reaching ESRD [2] , and those reaching ESRD have different outcomes and therapeutic options. Guidelines suggest starting patient education about treatment modalities at an estimated glomerular filtration rate (eGFR) of 30 mL/min/ 1.73 m 2 in most patients with rates of decline of 2-5 mL/min/ year and reaching final modality decisions at 20 mL/min/1.73 m 2 [3, 4] . In optimal individualized care, after the nephrologist presents and explains the therapeutic options, a treatment (including advance care) plan that incorporates the possibility of change should be jointly chosen [5] . A review of qualitative studies of this decision-making process noted its complexity, its dynamic evolution over time and towards death and the multifaceted factors that influence patients and health professionals differently [6] . A better description of how ESRD treatment plans are decided and their effect on outcomes of elderly patients reaching advanced CKD could improve their management [7] [8] [9] . However, this age group is often referred late to nephrologists for various reasons [10, 11] . But even when referral is early, dialysis initiation is frequently suboptimal (i.e. dialysis starts without fistula or outside hospital) [12] . The elderly are also at high risk of unplanned dialysis, a strong prognostic factor for death in the first 6 months of dialysis [13] . The conservative care approach must be discussed and offered to this population as well as distinguished from postponing the dialysis decision with a stable clinical status (i.e. few clinical uraemic symptoms and a stable GFR) [14] . A 2009 European survey found that nephrologists would recommend conservative care to $15% of patients of all ages reaching ESRD in specific medical situations [15] . Adequate descriptions of conservative care practices are sparse and mostly from the UK and USA [16] [17] [18] [19] . Finally, no prospective studies describe treatment planning for elderly patients with advanced CKD that integrates not only dialysis but also postponed dialysis or conservative care because patients decided not to pursue dialysis or nephrologists recommended against it. Our PSPA (Parcours de soins des personnes âgées: Treatment pathways for elderly patients) prospective cohort study aimed to determine the uptake of dialysis, dialysis start conditions and survival among patients who decided for or against dialysis or postponed this decision.
M A T E R I A L S A N D M E T H O D S

Patients
Patients recruited by nephrologists at 24 nephrology centres throughout France (listed in the appendix as collaborators) met the following inclusion criteria: >75 years of age, CKD with eGFR <20 mL/min/1.73 m 2 [estimated by the simplified MDRD formula] and at least one nephrology clinic visit before enrolment. Consecutive inclusion of in-and outpatients took place over 4 months in each centre, with all patients included within 1 year (2009-10).
Secondarily, we excluded five patients whose kidney function improved, with GFR persistently >45 mL/min/1.73 m 2 , one patient with a previous kidney transplant and two late referral patients (i.e. who started dialysis without previous nephrologist care).
Exposure variables. The exposure variables were the dialysis components of the treatment plans reported by the nephrologists in a questionnaire as a multiple-choice question, with the following four answers, only one of which could be chosen [20] at baseline: (i) ongoing evaluation of the patient's clinical condition and patient preferences after discussion ('evaluation'); (ii) postponement of decision about dialysis because of stable clinical condition ('stable');
(iii) decision to start dialysis when it becomes necessary ('dialysis') and (iv) nephrologist's decision that dialysis is not appropriate ('no dialysis-nephrologist') or patient's decision against dialysis ('no dialysis-patient').
We defined the baseline treatment plan as the treatment recorded by the nephrologist at 3 months or at least before 6 months after inclusion. This definition was used because 17% (n ¼ 99) of patients had evaluation as a plan at inclusion; two died before the treatment plan changed and before 6 months of follow-up. Nephrologists recorded the treatment plan at inclusion and at each subsequent visit during the follow-up, depending on changes in their own opinion or the patients' preference.
To study the course of the treatment plan over time, considered retrospectively at the end of follow-up, we described changes and used a second exposure item called 'follow-up plan': (i) if the plan never changed, the follow-up plan was the same as the baseline plan; (ii) if a stable patient's plan was reported to be dialysis at least once, the patient's follow-up plan was classified as dialysis unless a no-dialysis plan was subsequently chosen; (iii) the follow-up plan was no dialysis-patient if the patients refused dialysis at least once and (iv) if the nephrologist ever reported no dialysis-nephrologist, it was the follow-up plan.
Outcomes. Outcomes in the overall cohort were death during the 5-year follow-up period without considering dialysis as a competing event and the first event of either death before dialysis or dialysis initiation. Outcomes for the subgroup of patients starting dialysis were dialysis-initiation conditions, medical reason for starting dialysis and death during the following 2 years.
Data collection
At baseline, demographic and clinical data including comorbidities and disabilities, mobility (walks without help, needs assistance or totally dependent for transfers), living at home or institutionalized and laboratory data were obtained from the nephrologist and the medical record [20] . At dialysis initiation, clinical and laboratory data and dialysis start conditions including its planning, central vascular catheter (CVC) use, first modality (peritoneal or haemodialysis) and medical reason were recorded. Information about dialysis withdrawal before death for patients on dialysis was subsequently recorded. These informations came from the nephrologist, medical record, and the French National REIN registry for renal replacement therapy (RRT).
Statistical methods
First, for the entire cohort we described baseline characteristics overall and according to the baseline plan. Normally distributed variables were expressed as mean 6 SD and compared by one-way analysis of variance (ANOVA). Qualitative values were compared with the chi-squared test. We then described the distribution of the population according to outcome (died without dialysis, alive on dialysis, death after dialysis and alive without dialysis) for the entire follow-up period with a stacked area chart. Survival for the overall cohort according to the baseline treatment plan, without considering dialysis as a competing event, was described with a Kaplan-Meier survival curve.
We studied the crude association of the baseline treatment plan with the first event (i.e. death before dialysis or dialysis start) and then after adjustment for baseline comorbidities with a cause-specific proportional hazards model (Cox regression analyses with censoring at the competing event) and with a Fine and Gray model for a sensitivity analysis [21] . We also examined the cumulative incidence of dialysis initiation or death before dialysis for the overall population according to a Fine and Gray model and present a graph of these results. Finally, a chart summarizes retrospectively the changes of the baseline plans over time into follow-up plans, with the distributions of both.
Second, for the subgroup starting dialysis we studied the association of the follow-up plan, defined before dialysis started, with dialysis-initiation conditions, nephrologist's reason for starting dialysis and patient survival 2 years after starting. The patient survival rate after starting dialysis according to the follow-up plan is presented with a Kaplan-Meier curve and compared. We also used a Cox regression model (univariate and multivariate) to analyse the follow-up plan's association with death after dialysis.
A P-value of 0.05 was the level for statistical significance in all analyses, which were conducted with SAS software, version 9.3 (SAS Institute, Cary, NC, USA) and the R package (cmprsk and crr; The R project for Statistical Computing, Vienna, Austria).
The study was approved by the institutional review board and ethics committee of the research institution and by the required national institutions (CCTIRS and CNIL) and registered at ClinicalTrials.gov (NCT02910908). . The median interval between the first nephrologist visit and study inclusion was 33 months (IQR 12-74). Patients had the following baseline dialysis treatment plans: stable for 232 (40%) patients, dialysis for 215 (38%), no dialysis-nephrologist for 70 (12%) and no dialysis-patient for 54 (9%). Table 1 describes the patients' characteristics according to the baseline plan. The stable group had the highest median eGFR. The no dialysis-nephrologist group included older patients with more comorbidities, unable to walk alone and more often institutionalized. The no dialysis-patient group was older, more often female and with more frequent behavioural disorders.
R E S U L T S
Baseline patient characteristics
Overall cohort outcomes
The mean 5-year overall cohort follow-up was 34.5 6 21 months. During follow-up, 288 (50%) patients started dialysis, 237 (42%) died before starting dialysis and 178 (31%) died afterwards. Overall survival at 5 years was 27%, with 158 patients still alive, 48 (8% of the initial cohort) without dialysis ( Figure 1 ). The median patient survival according to the baseline plan was 40 (IQR 19-60) months for stable and for dialysis, 25 (IQR 11-45) months for no dialysis-patient and 6 (IQR 4-19) months for no dialysis-nephrologist (P < 0.05) ( Figure 2 ).
Baseline treatment plan and first event
The baseline treatment plan was associated with the first event (i.e. death before dialysis or dialysis start) during the 5-year follow-up period. The cumulative incidence rates of dialysis initiation were 97% in the dialysis group, 51% in the stable group, 38% in the no dialysis-patient group and 0.5% in the no dialysis-nephrologist group (Figure 3a ) and the cumulative incidence rates of death before starting dialysis were 51, 63, 82 and 99%, respectively ( Figure 3b ). After adjustment for comorbidities [i.e. age, gender, systolic blood pressure (SBP), body mass index (BMI), diabetes, active cancer, chronic respiratory failure, congestive heart failure, dysrhythmia, cerebrovascular disease, peripheral vascular disease, behavioural disorders, mobility, living at home, haemoglobin and proteinuria], the association between baseline treatment plan and first event was not modified ( Figure 3 ). The specific risk factors associated with starting dialysis or dying are presented in the supplementary data (Supplementary data, Table S1 ). A sensitivity analysis showed similar results for the risk analyses with Cox cause-specific regression and the Fine and Gray model (data not shown).
Change from baseline to follow-up treatment plans
During follow-up, the median number of treatment plan mentions per patient was 4 (IQR 3-9). Baseline plans evolved towards specifying eventual dialysis or refusal (Figure 4 ). In all, 85 (15%) patients refused dialysis at least once and nephrologists considered it was not appropriate for another 100 (17%). Overall, the follow-up plan was no dialysis for 185 (32%), with 118 (20%) considered stable and a consistent dialysis plan for 268 (47%).
Outcomes according to follow-up plans in patients starting dialysis
Among the 288 (50%) patients who started dialysis during follow-up, the follow-up treatment plan was dialysis for 236 (82%) patients, stable for 26 (9%), no dialysis-patient for 24 (8%) ( Table 2 ) and 1 despite a no dialysis-nephrologist plan.
The mean follow-up was 12 6 3 months after starting dialysis for a 2-year follow-up period. One stable patient was treated with pre-emptive kidney transplantation. Those with a no dialysis-patient plan were significantly older and started dialysis more often as an emergency and with a CVC than patients in the dialysis group (20% versus 63% unplanned dialysis and 22% versus 58% with CVC) ( Table 2 ). The stable group had an intermediate profile with 32% unplanned dialysis and 48% CVC. Nephrologists reported starting dialysis primarily for eGFR level, hypervolemia and weight loss. They also reported different criteria for starting dialysis in the no dialysis-patient group, which had more frequent weight loss, metabolic acidosis and hyperkalaemia as well as a lower median eGFR at dialysis start (6.0 mL/min/1.73 m 2 ) than the other two groups. The follow-up plan before starting dialysis was associated with 2-year survival after dialysis start (logrank P ¼ 0.008) ( Figure 5 ). After adjustment for clinical characteristics, the hazard ratios (HRs) for the follow-up treatment plan did not differ significantly from 1, but risk of death trended higher in the no dialysis-patient group compared with the dialysis group {HR 1.5 [95% confidence interval (CI) 0.8-2.9]}. Age, chronic respiratory failure, impaired mobility, behavioural disorders and anaemia were independently 58 (10) 26 (11) 15 (7) 12 (17) 5 (9) 0.17 Behavioural disorders or dementia, n (%) 53 (9) 11 (5) (28) 61 (26) 61 (28) 25 (36) 11 (20) 0.27 Cerebrovascular disease, n (%)
76 (13) 26 (11) 32 (15) 14 (20) 4 (7) 0.12 Chronic respiratory disease, n (%)
63 (11) 26 (11) 21 (10) 9 (13) Outcomes in elderly patients with advanced CKD associated with death within 2 years (Supplementary data, Table S2 ). Of the 19 patients who finally stopped dialysis, the follow-up treatment plan had been dialysis for 11 of 236 (5%), stable for 5 of 26 (20%) and no dialysis-patient for 3 of 24 (13%).
D I S C U S S I O N
After 5 years of follow-up, half of our prospective cohort of elderly patients with advanced CKD had started dialysis, 41% died before doing so and only 27% were still alive (8% without and 19% with dialysis). This poor prognosis confirms the need to consider other perspectives such as quality of life and patients' end-of-life wishes [22] . Patients' baseline treatment plans were associated with their clinical condition. As in the European nephrologist survey, those whose nephrologists did not consider dialysis an option for them were older, had more comorbidities, especially behavioural disorders or dementia, more frequent mobility disabilities and lived at home less often. They were more frequently female, too, although the cause of this gender-based difference is not well understood. The clinical characteristics of the baseline stable group (41%) did not differ from those of the dialysis group except for their higher eGFR and lower proteinuria. Three points may explain this high rate of stable patients: first, our cohort was already under nephrologists' care; second, GFR decreases more slowly in older than younger patients [2] and third, recruitment of patients subjected the study to survivorship (prevalence-incidence) bias. The baseline treatment plan was independently associated with death before dialysis and with starting dialysis, as were some clinical characteristics. During follow-up, the dialysis-related treatment plan changed mostly for those in the groups with baseline stable and dialysis plans but less often for no dialysis group. Finally, at the end of the 5-year period, 32% of the cohort had still not chosen a plan concerning dialysis if needed. This important result shows that patients frequently do not articulate explicit decisions about dialysis until very late in their disease course. Patients who began dialysis despite either a stable or no dialysis-patient plan started dialysis later and more often without permanent access than those with dialysis as a follow-up plan. Perhaps surprisingly, however, their dialysis survival was similar after adjustment. Despite its correlation with clinical status, the treatment plan influences patient care more than outcomes, affecting, for example, the still-controversial questions of timing for vascular access placement and organization of supportive care [14, 23] .
After 5 years, only 2 (1.6%) of the 124 patients without a baseline no-dialysis treatment plan changed their plan for dialysis during follow-up, but 13 (10.5%) of them nonetheless started dialysis. A recent prospective Australian study reported 8% of those initially choosing conservative care switched to dialysis treatment [24] . Conversely, of those who chose dialysis at baseline, 8% changed their mind, while 88% started dialysis. These results illustrate the changes possible in patients' choices over time, shows the health care system's adaptability and demonstrates the need to consider both baseline and follow-up plans in studies comparing outcomes. Given the number of no dialysis-patient plans (54 at baseline, of whom 7 changed to a different plan and another 38 chose it first during follow-up), the 24 with this plan who started dialysis and the many other changes in plans during follow-up, nephrologists should regularly evaluate patients' preferences. Both the early and late information should note that, independent of clinical condition, the no dialysis-patient option is associated with a higher risk of unplanned dialysis, greater use of a CVC and higher mortality after dialysis starts, if it does. Changes in treatment plans appear less likely when nephrologists, rather than patients, decide against dialysis. Finally, this prospective cohort study confirms that the conservative care option (i.e. a no-dialysis plan) in this nephrologist-treated population is common, $30%. In the 2013 European survey covering all patient age groups, nephrologists reported offering conservative care to 10% of their patients and an additional 5% (IQR 2-10) of the patients chose conservative care by refusing RRT [15] . These results confirm the need to define and provide individualized supportive care in this population [25] and to consider the follow-up plan in evaluating the quality of care at dialysis initiation.
Of the 241 patients classified as stable at baseline, 117 (48%) remained in this group throughout follow-up. Their higher (a) ( b) FIGURE 3: Cumulative incidence of dialysis (death before dialysis is considered a competing event) and cumulative incidence of death before dialysis (dialysis is considered a competing event) according to the baseline treatment plan in univariate analysis according to the Fine and Gray analysis and the risk of dialysis or death according to the baseline treatment plan (HR) after adjustment for comorbidities (both Cox specific analyses). *Adjusted for age, gender, systolic blood pressure, BMI, diabetes, active cancer, chronic respiratory failure, congestive heart failure, dysrhythmia, cerebrovascular disease, peripheral vascular disease, behavioural disorders, mobility, living at home, haemoglobin and proteinuria. ref, reference.
follow-up treatment plan FIGURE 4: Baseline plans, their distribution and their changes into follow-up plans, viewed retrospectively with their distribution at the end of follow-up. ND.pt, no dialysis-patient; ND.Ne, no dialysis-nephrologist. frequency of changes to a plan without dialysis suggests that a dialysis plan was postponed not only because of clinical stability, but also because the patient was undecided or the patient or nephrologist or both had doubts about its benefits. This apparent stability should be reassessed regularly and may also be changed by an intercurrent event that may precipitate the decision to start dialysis. As in the no dialysis-patient group, the stable option was associated with greater risk of unplanned dialysis and CVC use and lower eGFR at dialysis start. Therefore time should be taken to explain, even to those patients with a stable clinical status, the different treatment options, including conservative care and advanced care planning, and to discuss vascular access and the risks associated with inadequate dialysis preparation; they should also be offered therapeutic education [5] . Little is known about the criteria nephrologists use in deciding the timing for starting dialysis in this elderly population. As in the European survey, the GFR level was the main reason for starting dialysis, but hypervolemia and patient preference were also important [26] . The reported causes for starting dialysis differed according to the treatment plan. The no dialysis-patient group that finally started dialysis did so at the lowest GFR levels and more frequently with hyperkalaemia. Loss of weight, a symptom included in the geriatric syndrome, was the third reason reported for starting dialysis, as reported elsewhere [27] .
The strength of this study is its multicentre prospective design, including >500 elderly patients with a median eGFR of 14 mL/min/1.73 m 2 at inclusion, a 5-year follow-up, no loss to follow-up and information about treatment plan changes during follow-up as well as outcomes after starting dialysis. Nonetheless, our study should be interpreted in light of the following limitations. First, because nephrologists included the patients, their likelihood of starting dialysis may be higher than that of the general elderly population with advanced CKD seen by general practitioners or geriatricians. Healthier patients with a better long-term prognosis may be referred to nephrologists earlier and thus have more time to discuss treatment options and more reason for an optimistic prognosis with dialysis, while we found a lower percentage of dialysis treatment among older patients, as did Wong et al. in the USA [28] . Nonetheless, it is possible that patients' participation in this study and the need to review the existence and type of plan at each visit modified their care. Accordingly, these results can be generalized only when a treatment plan is regularly discussed and recorded. Similarly, our results are not applicable to patients referred late [11] .
Second, our study did not collect information on the decision-making process that led to the treatment plan, especially to the nephrologist's decision that dialysis is not indicated. Third, the treatment plan reported by nephrologists reflects their view of the treatment plan, which may be different from the patient's understanding.
In conclusion, in our prospective 5-year study of elderly patients with advanced CKD, only half started dialysis and only a quarter were still alive at the end of follow-up. We showed that elderly patients with very advanced CKD frequently do not articulate explicit decisions about dialysis until very late in their disease course; consequently, they start dialysis later and without permanent access. Perhaps surprisingly, however, their dialysis survival is similar to that of patients with a dialysis plan. Our results suggest that determining a treatment plan early and re-evaluating it regularly will enable better organization of patient care, whether it is dialysis or conservative management. They also suggest that the course of the treatment plan and the patient's care trajectory upstream are essential information for evaluating dialysis initiation conditions as a quality criterion for medical practice.
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